MedPath

A clinical trial to study the accuracy of a novel technology-enabled tool to identify the risk of dyslexia in children aged 6 to 10 years.

Not Applicable
Registration Number
CTRI/2024/04/066300
Lead Sponsor
Teena Ajit Paul
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. As participants are underaged, guardian consent and verbal consent from participant will be primary criteria for inclusion.

2.Participants should demonstrate a basic level of reading comprehension in the language the screening is conducted.

Exclusion Criteria

The following individual will be excluded:

1. non-consenting children.

2. Children with visual impairment.

3. Children with significantly below average intelligence.

4. Children with reading comprehension below the test threshold.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be measured as percent accuracy of the tool determined by comparison with an assessment tool, the NIMHANS Neuropsychological Battery for Children.Timepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
The secondary outcome will be the safety of the device used by recording any negative outcomes.Timepoint: 1 hour from test.
© Copyright 2025. All Rights Reserved by MedPath